Acesion Pharma

Denmark
Copenhagen, Capital Region, Denmark
45 44 64 08 76 ★

Company profile

Acesion Pharma company profile

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Business identity

Contact email
[email protected]
Phone number
45 44 64 08 76
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2011-01-01

Headquarters

Headquarters
Copenhagen, Capital Region, Denmark
Postal code
DK-2200
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
6
Total equity funding
$67.7M
Last funding
Series B / $47.6M / 2023-09-26
Last equity funding
Series B / $47.6M
Investors
7
Lead investors
4
Founders
2
Articles
21

Founders and investors

Founders

Morten GrunnetUlrik Sørensen

Lead investors

Alpha Wave GlobalCanaan PartnersNovo HoldingsWellcome Trust

Investors

Alpha Wave GlobalCanaan PartnersNovo HoldingsSeed CapitalWellcome Trust

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.